- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 235/20 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Patent holdings for IPC class C07C 235/20
Total number of patents in this class: 140
10-year publication summary
|
11
|
14
|
8
|
17
|
10
|
6
|
15
|
11
|
3
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20574 |
13 |
| Corsair Pharma, Inc. | 37 |
12 |
| Insmed Incorporated | 267 |
8 |
| Autobahn Therapeutics, Inc. | 43 |
6 |
| Oregon Health & Science University | 754 |
5 |
| Theravance Biopharma R&D IP, LLC | 425 |
5 |
| Senomyx, Inc. | 67 |
4 |
| Firmenich Incorporated | 157 |
4 |
| Envista | 4 |
4 |
| BASF SE | 21150 |
3 |
| Cheminova A/S | 142 |
3 |
| Novocodex Biopharmaceuticals Co., Ltd. | 17 |
3 |
| FUJIFILM Corporation | 30294 |
2 |
| Glaxosmithkline Intellectual Property Development Limited | 773 |
2 |
| The United States of America as represented by the Secretary of the Navy | 2840 |
2 |
| Arkema France | 4188 |
2 |
| Aurimmed Pharma, Inc. | 7 |
2 |
| BioTheryX, Inc. | 96 |
2 |
| ChemoCentryx, Inc. | 370 |
2 |
| China State Institute of Pharmaceutical Industry | 21 |
2 |
| Other owners | 54 |